Why is Nectar Lifesci. falling/rising?

As of 10-Nov, Nectar Lifescience Ltd's stock price is currently at 14.75, reflecting an increase of 0.1 or 0.68%. The stock has shown a positive trend over the last two days, gaining 5.51% during this period. However, it has underperformed its sector by 0.37% today. Despite being higher than the 20-day and 50-day moving averages, the stock remains lower than the 5-day, 100-day, and 200-day moving averages. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 73.18% compared to the 5-day average. Year-to-date, the stock has experienced a substantial decline of 62.18%, contrasting sharply with the Sensex's gain of 6.91% over the same period.
Broader Market Context: In the short term, Nectar Lifescience's performance has been weaker than the benchmark Sensex, which has declined by 0.53% over the past week while the stock itself has fallen by 1.01%. This underperformance highlights the challenges the company faces in attracting investor interest, particularly given the significant drop in delivery volume. The broader market context shows that while the stock has seen some recent gains, its long-term performance remains concerning, with a year-over-year decline of 59.70% compared to the Sensex's increase of 5.09%.